BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11171003)

  • 1. Urinary tract pathogens in complicated infection and in elderly individuals.
    Nicolle LE
    J Infect Dis; 2001 Mar; 183 Suppl 1():S5-8. PubMed ID: 11171003
    [No Abstract]   [Full Text] [Related]  

  • 2. A Rare Opportunist,
    Learman BS; Brauer AL; Eaton KA; Armbruster CE
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary tract infections. Virulence factors in E coli bacteria].
    Kaijser B
    Lakartidningen; 1979 May; 76(21):2032-3. PubMed ID: 376981
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of bacterial adherence in urinary tract infections].
    Gromska W
    Postepy Hig Med Dosw; 1985; 39(3):245-63. PubMed ID: 2870490
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urease activity of bacteria in urine].
    Arai Y; Takeuchi H; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1989 Feb; 35(2):277-81. PubMed ID: 2500012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
    Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J
    Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of bacterial urease.
    Griffith DP; Musher DM; Campbell JW
    Invest Urol; 1973 Nov; 11(3):234-8. PubMed ID: 4201416
    [No Abstract]   [Full Text] [Related]  

  • 9. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?
    Marrs CF; Zhang L; Foxman B
    FEMS Microbiol Lett; 2005 Nov; 252(2):183-90. PubMed ID: 16165319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
    Labat F; Pradillon O; Garry L; Peuchmaur M; Fantin B; Denamur E
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):317-21. PubMed ID: 15907455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. d-Serine Degradation by Proteus mirabilis Contributes to Fitness during Single-Species and Polymicrobial Catheter-Associated Urinary Tract Infection.
    Brauer AL; White AN; Learman BS; Johnson AO; Armbruster CE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30814316
    [No Abstract]   [Full Text] [Related]  

  • 12. Blueprinting the regulatory response of Escherichia coli to the urinary tract.
    Seed PC; Hultgren SJ
    Trends Microbiol; 2005 Jun; 13(6):246-8. PubMed ID: 15936653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.
    Wang MC; Tseng CC; Chen CY; Wu JJ; Huang JJ
    Clin Infect Dis; 2002 Nov; 35(10):1161-6. PubMed ID: 12410475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum resistance of Escherichia coli strains causing urinary tract infection and diarrhoea in relation to alpha haemolysin production and O type.
    Rizvi M; Kumar S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):504-6. PubMed ID: 15025325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent reactive arthritis associated with urinary tract infection by Escherichia coli.
    Laasila K; Leirisalo-Repo M
    J Rheumatol; 1999 Oct; 26(10):2277-9. PubMed ID: 10529156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical implications of E. coli pathogenic factors in patients with urinary infection].
    Khodyreva LA; Bondarenko VM; Vershinin AE; Perepanova TS; Dudareva AA; Orlova EV; Lavrinova LN
    Urologiia; 2006; (4):35-40. PubMed ID: 17058679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of uropathogenic Escherichia coli with host uroepithelium.
    Kau AL; Hunstad DA; Hultgren SJ
    Curr Opin Microbiol; 2005 Feb; 8(1):54-9. PubMed ID: 15694857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection.
    Farshad S; Emamghorashi F
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):613-7. PubMed ID: 19587502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia.
    Moreno E; Planells I; Prats G; Planes AM; Moreno G; Andreu A
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):93-9. PubMed ID: 16168618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.